Kay, Jonathan http://orcid.org/0000-0002-8970-4260
Article History
First Online: 23 December 2019
Competing interests
: J.K. has received research support (paid to the University of Massachusetts Medical School) from Gilead Sciences, Pfizer and UCB and has served as a consultant to Alvotech Suisse, Boehringer Ingelheim, Celltrion Healthcare, Horizon Therapeutics, Kolon TissueGene, Merck Sharp & Dohme, Mylan, Novartis, Pfizer, Samsung Bioepis, Sandoz and UCB.